SUBSCRIBE
SUBSCRIBE
News   Drug Development

Infinity Pharmaceuticals, Inc. Announces Advancement of Lead Development Program and Third Quarter Financial Results

October 30, 2007 | 
1 min read

CAMBRIDGE, Mass., Oct. 29, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced results for the third quarter of 2007.

Clinical research Phase I Earnings
Infinity Pharmaceuticals Inc.
MORE ON THIS TOPIC
Funding
Nuvig Ropes in $161M Series B From Big Pharma Players for Autoimmune Indications
December 5, 2024
 · 
1 min read
 · 
Kate Goodwin
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
GSK's headquarters office building in Poznan, Poland
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
December 4, 2024
 · 
1 min read
 · 
Kate Goodwin
Crowdfunding concept with money icon and human hands in retro 80s collage mixed media vector illustration. Idea for financing business project, funding, philanthropy, cooperation, bank credit and startup development.
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
December 4, 2024
 · 
2 min read
 · 
Heather McKenzie